In AML with inv(3)(q21q26) the GATA2 enhancer translocates 3’ of EVI115 (Fig. 7a), leaving the enhancer-interacting CTCF site in position with respect to EVI1 as well. Here, RUNX1 is linked to acute myeloid leukemia.